Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2003
05/08/2003WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor
05/08/2003WO2003037252A2 Tyrosine kinase inhibitors
05/08/2003WO2003002529A3 Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
05/08/2003WO2001079194A9 Method for obtaining derivatives of [[(pyridil substituted)methyl]thio]benzimidazol
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030088099 Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
05/08/2003US20030088096 Preparation by cleavage of triazolopyrimidines or by cyanoamination of sulfonylpyrimidines
05/08/2003US20030088094 Novel synthesis and crystallization of piperazine ring-containing compounds
05/08/2003US20030087999 Thermosetting resin compositions containing maleimide and/or vinyl compounds
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087940 Substituted imidazoles and thiazoles
05/08/2003US20030087936 Treating enterovirus infection
05/08/2003US20030087931 Nitrogen heteroaromatic ring connected with the same or another aromatic ring through a triazine distribution agent; anticancer agents
05/08/2003US20030087925 Benzoamide piperidine containing compounds and related compounds
05/08/2003US20030087923 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087921 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
05/08/2003US20030087920 Butyne diol derivatives
05/08/2003US20030087919 Rho-kinase inhibitors
05/08/2003US20030087912 Aryl oxime-piperazines useful as CCR5 antagonists
05/08/2003US20030087910 E.g., O-(2-quinolinylmethyl)-N-quinaldoyl-D,L-tyrosine
05/08/2003US20030087909 Having an attached non-aromatic heterocyclic ring
05/08/2003US20030087908 Substituted triazinyl amide derivatives and methods of use
05/08/2003US20030087907 Quinoline derivatives and quinazoline derivatives having azolyl group
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087899 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound.
05/08/2003US20030087894 Vitronectin receptor antagonist
05/08/2003US20030087891 2-Amino-6-(2,4,5-substituted-phenyl)-pyridines
05/08/2003US20030087890 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
05/08/2003US20030087881 Quinazoline derivatives used to treat cancer, restenosis, atherosclerosis, endometriosis, and psoriasis
05/08/2003US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030086968 Administering to human an amount of (-) pantoprazole, or a pharmaceutically acceptable salt thereof, substantially free of its (+) stereoisomer to alleviate or palliate ulcers
05/08/2003CA2468761A1 Novel anticancer compounds
05/08/2003CA2466424A1 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003CA2465429A1 Compounds and method for the treatment of overactive bladder
05/08/2003CA2465382A1 Indole compound and medicinal use thereof
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2465305A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003CA2465140A1 Method for the treatment of overactive bladder
05/08/2003CA2464995A1 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464924A1 Heteroaromatic carboxamide derivatives for the treatment of inflammation
05/08/2003CA2464342A1 Therapeutic isoquinoline compounds
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308444A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha Levels
05/07/2003EP1308441A1 2-aminopyridine compounds and use thereof as drugs
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308160A1 Highly absorbable solid preparation
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307445A1 Benzofuran derivatives and their use as antibacterial agents
05/07/2003EP1307444A2 Substituted heterocyclic amides
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1307202A1 Method for the treatment of overactive bladder
05/07/2003EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
05/07/2003EP1307192A1 New use of angiotensin ii antagonists
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP1097698B1 Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain
05/07/2003EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules
05/07/2003EP1054863B1 2-aminoquinoline derivatives having d4-agonistic activity
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0912520B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
05/07/2003EP0885190B1 N-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
05/07/2003EP0869791B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0814807B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/07/2003EP0807630B1 Heterocyclic compounds
05/07/2003EP0806416B1 Huperzine a derivatives, their preparation and their use
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0751765B1 Sulfonamide derivatives and their use
05/07/2003CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1416420A 1,2,3,4-tetrahydroisoquinoline derivatives
05/07/2003CN1416419A 4-aminopicolinates and their use as herbicides
05/07/2003CN1416346A Peotease inhibitors
05/07/2003CN1415613A Stable composition of medicaments of desloratadine salt or medicament containing salt utilized to cure allergic disease
05/07/2003CN1107766C Sizing of paper
05/07/2003CN1107673C Pesticidal 1-aryl-3-iminopyrazoles
05/07/2003CN1107672C Intermediate for preparing pyrazole derivatives
05/07/2003CN1107671C Imide derivatives
05/07/2003CN1107503C Optically pure compoun as medicinal use
05/06/2003US6559313 Adenosine derivatives such as (1S,2R,3S,4R)-2,3-dihydroxy-4-(6-(1-(4-trifluormethylpyridin-2-yl)pyrrolidin-3(S)-yl-amino)purin-9-yl)cyclopentanecarboxylic acid isopropylamide
1 ... 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 ... 1080